FDA Approves DILTIAZEM HYDROCHLORIDE — Zydus Pharmaceuticals (USA) Inc.

# FDA Approves Zydus Pharmaceuticals' Generic Diltiazem Hydrochloride Zydus Pharmaceuticals (USA) Inc. received FDA approval for its generic diltiazem hydrochloride oral formulation, expanding the competitive generic market for this widely-used calcium channel blocker used to treat hypertension and angina. The approval is expected to increase price competition and improve patient access to the cardiovascular medication.